Quality of life in brain metastases radiation trials: a literature review

BACKGROUND: An estimated 20%–40% of cancer patients will develop brain metastases. Whole-brain radiotherapy (wbrt) is the standard treatment for patients with brain metastases. Although wbrt can reduce neurologic symptoms, the median survival following wbrt is between 3 and 6 months. Given this limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, J., Hird, A., Kirou–Mauro, A., Napolskikh, J., Chow, E.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2008
Materias:
E-Manuscript Article Summary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582512/
https://www.ncbi.nlm.nih.gov/pubmed/19008990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582512/
https://www.ncbi.nlm.nih.gov/pubmed/19008990

Ejemplares similares